Processa pharmaceuticals to present at the medinvest oncology investor conference

Hanover, md, nov. 30, 2023 (globe newswire) -- processa pharmaceuticals, inc. (nasdaq: pcsa) (“processa” or the “company”), a clinical-stage pharmaceutical company focused on developing the next generation of chemotherapeutic drugs to improve the efficacy and safety for patients suffering from cancer, announces that dr. david young, president of research and development, will present virtually at the medinvest oncology investor conference.
PCSA Ratings Summary
PCSA Quant Ranking